- Home
- ROIV vs CFR Comparison
ROIV vs CFR Comparison
Compare ROIV & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | CFR |
|---|---|---|
| Founded | 2014 | 1868 |
| Country | United Kingdom | United States |
| Employees | N/A | 6008 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 8.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | CFR |
|---|---|---|
| Price | $28.88 | $140.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 13 |
| Target Price | $28.94 | ★ $142.31 |
| AVG Volume (30 Days) | ★ 5.8M | 446.8K |
| Earning Date | 05-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,260,000.00 | N/A |
| Revenue This Year | N/A | $9.72 |
| Revenue Next Year | $744.61 | $4.70 |
| P/E Ratio | ★ N/A | $14.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.71 | $119.00 |
| 52 Week High | $32.79 | $148.97 |
Technical Indicators
Market Signals| Indicator | ROIV | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 56.29 |
| Support Level | $26.95 | $133.95 |
| Resistance Level | $30.10 | $140.82 |
| Average True Range (ATR) | 1.11 | 2.42 |
| MACD | -0.15 | 0.24 |
| Stochastic Oscillator | 20.03 | 88.93 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.